Ironwood Pharmaceuticals (IRWD) Other financing activities (2010 - 2026)

Ironwood Pharmaceuticals has disclosed Other financing activities across 14 years of filings, most recently posting -$2000.0 for Q1 2026.

• Other financing activities for Q1 2026 came in at -$2000.0, down 133.33% year-over-year; the trailing twelve-month figure through Mar 2026 was -$5000.0 (up 99.94% YoY), and the FY2025 annual result was $3000.0, down 99.87% from the prior year.
• Other financing activities came in at -$2000.0 for Q1 2026 at Ironwood Pharmaceuticals, up from -$92000.0 in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $10.1 million in Q1 2024 to a low of -$8.7 million in Q3 2024.
• The 5-year median for Other financing activities is $750000.0 (2024), against an average of $1.1 million.
• Peak annual rise in Other financing activities reached 517.62% in 2024, while the deepest fall reached 66676.92% in 2024.
• Ironwood Pharmaceuticals' Other financing activities stood at $5.2 million in 2022, then sank by 66.85% to $1.7 million in 2023, then tumbled by 94.74% to $90000.0 in 2024, then slumped by 202.22% to -$92000.0 in 2025, then soared by 97.83% to -$2000.0 in 2026.
• The last three Other financing activities figures came in at -$2000.0 (Q1 2026), -$92000.0 (Q4 2025), and $1000.0 (Q3 2025), per Business Quant data.